Postoperative symptoms of psychosis after deep brain stimulation in patients with Parkinson's disease

Azam A. Qureshi, Jennifer J. Cheng, Abraham N. Sunshine, Adela Wu, Gregory M Pontone, Nicola Cascella, Frederick Lenz, Stephen E. Grill, William S Anderson

Research output: Contribution to journalArticle

Abstract

Object: Cases of postoperative psychosis in Parkinson's disease patients receiving deep brain stimulation (DBS) treatment have previously been published. However, the magnitude of symptom incidence and the clinical risk factors are currently unknown. This retrospective study sheds light on these issues by investigating psychosis in a group of 128 Parkinson's disease patients who received DBS implants. Methods: A retrospective chart review was performed to obtain surgery dates, follow-up clinic visit dates, and associated stimulation parameter settings (contacts in use and the polarity of each along with stimulation voltage, frequency, and pulse width) for each patient. Unified Parkinson's Disease Rating Scale II Thought Disorder scores, used as a clinical assessment tool to evaluate the presence of psychosis at each visit, were also collected. The data were compiled into a database and analyzed. Results: The lifetime incidence of psychosis in this cohort of patients was 28.1%. The data suggest that risk of psychosis remains fairly constant throughout the first 5 years after implantation of a DBS system and that patients older at the time of receiving the first DBS implant are not only more likely to develop psychosis, but also to develop symptoms sooner than their younger counterparts. Further analysis provides evidence that psychosis is largely independent of the clinically used electrode contact and of stimulation parameters prior to psychosis onset. Conclusions: Although symptoms of psychosis are widely seen in patients with Parkinson's disease in the years following stimulator placement, results of the present suggest that most psychoses occurring postoperatively are likely independent of implantation and stimulation settings.

Original languageEnglish (US)
Article numberE5
JournalNeurosurgical Focus
Volume38
Issue number6
DOIs
StatePublished - 2015

Fingerprint

Deep Brain Stimulation
Psychotic Disorders
Parkinson Disease
Incidence
Ambulatory Care
Electrodes
Retrospective Studies
Databases

Keywords

  • Deep brain stimulation
  • Neurosurgery
  • Parkinson's disease
  • Psychiatry
  • Psychosis

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Postoperative symptoms of psychosis after deep brain stimulation in patients with Parkinson's disease. / Qureshi, Azam A.; Cheng, Jennifer J.; Sunshine, Abraham N.; Wu, Adela; Pontone, Gregory M; Cascella, Nicola; Lenz, Frederick; Grill, Stephen E.; Anderson, William S.

In: Neurosurgical Focus, Vol. 38, No. 6, E5, 2015.

Research output: Contribution to journalArticle

Qureshi, Azam A. ; Cheng, Jennifer J. ; Sunshine, Abraham N. ; Wu, Adela ; Pontone, Gregory M ; Cascella, Nicola ; Lenz, Frederick ; Grill, Stephen E. ; Anderson, William S. / Postoperative symptoms of psychosis after deep brain stimulation in patients with Parkinson's disease. In: Neurosurgical Focus. 2015 ; Vol. 38, No. 6.
@article{2c725c8f2f2e4e3dba1e8c74628a9b13,
title = "Postoperative symptoms of psychosis after deep brain stimulation in patients with Parkinson's disease",
abstract = "Object: Cases of postoperative psychosis in Parkinson's disease patients receiving deep brain stimulation (DBS) treatment have previously been published. However, the magnitude of symptom incidence and the clinical risk factors are currently unknown. This retrospective study sheds light on these issues by investigating psychosis in a group of 128 Parkinson's disease patients who received DBS implants. Methods: A retrospective chart review was performed to obtain surgery dates, follow-up clinic visit dates, and associated stimulation parameter settings (contacts in use and the polarity of each along with stimulation voltage, frequency, and pulse width) for each patient. Unified Parkinson's Disease Rating Scale II Thought Disorder scores, used as a clinical assessment tool to evaluate the presence of psychosis at each visit, were also collected. The data were compiled into a database and analyzed. Results: The lifetime incidence of psychosis in this cohort of patients was 28.1{\%}. The data suggest that risk of psychosis remains fairly constant throughout the first 5 years after implantation of a DBS system and that patients older at the time of receiving the first DBS implant are not only more likely to develop psychosis, but also to develop symptoms sooner than their younger counterparts. Further analysis provides evidence that psychosis is largely independent of the clinically used electrode contact and of stimulation parameters prior to psychosis onset. Conclusions: Although symptoms of psychosis are widely seen in patients with Parkinson's disease in the years following stimulator placement, results of the present suggest that most psychoses occurring postoperatively are likely independent of implantation and stimulation settings.",
keywords = "Deep brain stimulation, Neurosurgery, Parkinson's disease, Psychiatry, Psychosis",
author = "Qureshi, {Azam A.} and Cheng, {Jennifer J.} and Sunshine, {Abraham N.} and Adela Wu and Pontone, {Gregory M} and Nicola Cascella and Frederick Lenz and Grill, {Stephen E.} and Anderson, {William S}",
year = "2015",
doi = "10.3171/2015.3.FOCUS1523",
language = "English (US)",
volume = "38",
journal = "Neurosurgical Focus",
issn = "1092-0684",
publisher = "American Association of Neurological Surgeons",
number = "6",

}

TY - JOUR

T1 - Postoperative symptoms of psychosis after deep brain stimulation in patients with Parkinson's disease

AU - Qureshi, Azam A.

AU - Cheng, Jennifer J.

AU - Sunshine, Abraham N.

AU - Wu, Adela

AU - Pontone, Gregory M

AU - Cascella, Nicola

AU - Lenz, Frederick

AU - Grill, Stephen E.

AU - Anderson, William S

PY - 2015

Y1 - 2015

N2 - Object: Cases of postoperative psychosis in Parkinson's disease patients receiving deep brain stimulation (DBS) treatment have previously been published. However, the magnitude of symptom incidence and the clinical risk factors are currently unknown. This retrospective study sheds light on these issues by investigating psychosis in a group of 128 Parkinson's disease patients who received DBS implants. Methods: A retrospective chart review was performed to obtain surgery dates, follow-up clinic visit dates, and associated stimulation parameter settings (contacts in use and the polarity of each along with stimulation voltage, frequency, and pulse width) for each patient. Unified Parkinson's Disease Rating Scale II Thought Disorder scores, used as a clinical assessment tool to evaluate the presence of psychosis at each visit, were also collected. The data were compiled into a database and analyzed. Results: The lifetime incidence of psychosis in this cohort of patients was 28.1%. The data suggest that risk of psychosis remains fairly constant throughout the first 5 years after implantation of a DBS system and that patients older at the time of receiving the first DBS implant are not only more likely to develop psychosis, but also to develop symptoms sooner than their younger counterparts. Further analysis provides evidence that psychosis is largely independent of the clinically used electrode contact and of stimulation parameters prior to psychosis onset. Conclusions: Although symptoms of psychosis are widely seen in patients with Parkinson's disease in the years following stimulator placement, results of the present suggest that most psychoses occurring postoperatively are likely independent of implantation and stimulation settings.

AB - Object: Cases of postoperative psychosis in Parkinson's disease patients receiving deep brain stimulation (DBS) treatment have previously been published. However, the magnitude of symptom incidence and the clinical risk factors are currently unknown. This retrospective study sheds light on these issues by investigating psychosis in a group of 128 Parkinson's disease patients who received DBS implants. Methods: A retrospective chart review was performed to obtain surgery dates, follow-up clinic visit dates, and associated stimulation parameter settings (contacts in use and the polarity of each along with stimulation voltage, frequency, and pulse width) for each patient. Unified Parkinson's Disease Rating Scale II Thought Disorder scores, used as a clinical assessment tool to evaluate the presence of psychosis at each visit, were also collected. The data were compiled into a database and analyzed. Results: The lifetime incidence of psychosis in this cohort of patients was 28.1%. The data suggest that risk of psychosis remains fairly constant throughout the first 5 years after implantation of a DBS system and that patients older at the time of receiving the first DBS implant are not only more likely to develop psychosis, but also to develop symptoms sooner than their younger counterparts. Further analysis provides evidence that psychosis is largely independent of the clinically used electrode contact and of stimulation parameters prior to psychosis onset. Conclusions: Although symptoms of psychosis are widely seen in patients with Parkinson's disease in the years following stimulator placement, results of the present suggest that most psychoses occurring postoperatively are likely independent of implantation and stimulation settings.

KW - Deep brain stimulation

KW - Neurosurgery

KW - Parkinson's disease

KW - Psychiatry

KW - Psychosis

UR - http://www.scopus.com/inward/record.url?scp=84931399145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931399145&partnerID=8YFLogxK

U2 - 10.3171/2015.3.FOCUS1523

DO - 10.3171/2015.3.FOCUS1523

M3 - Article

C2 - 26030705

AN - SCOPUS:84931399145

VL - 38

JO - Neurosurgical Focus

JF - Neurosurgical Focus

SN - 1092-0684

IS - 6

M1 - E5

ER -